Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Breast cancer is a major cause of mortality, with conventional therapies often failing due to resistance, recurrence, and metastasis.
• Photodynamic therapy (PDT) offers a selective tumor-killing approach using photosensitizers and reactive oxygen species (ROS), but faces challenges like tumor hypoxia and poor drug uptake.
• Liposomal nanocarriers present a solution for targeted delivery, improved photosensitizer accumulation, and enhanced cellular internalization in breast cancer treatment.

Purpose of the Study:

• To review recent advancements in liposome-based photodynamic therapy (PDT) for breast cancer.
• To highlight the integration of multimodal therapeutic strategies with liposome-based PDT.
• To discuss preclinical and clinical outcomes, manufacturing, and immune evasion strategies for liposomal PDT.

Main Methods:

• Review of current literature on liposome-based PDT for breast cancer.
• Analysis of strategies for overcoming tumor microenvironment barriers.
• Examination of combinational therapeutic approaches integrating PDT with other modalities.

Main Results:

• Antigen-targeted liposomal nanocarriers improve PDT efficacy by enabling targeted delivery and overcoming biological barriers.
• Multifunctional liposomes support combination therapies (chemotherapy, photothermal therapy, gene therapy, X-PDT, immunotherapy), enhancing antitumor effects.
• Recent advances show promise in preclinical and early clinical settings, with considerations for manufacturing and immune response.

Conclusions:

• Liposome-based PDT, especially when integrated with other therapies, represents a significant advancement in breast cancer treatment.
• Targeted nanocarrier systems are crucial for overcoming PDT limitations and improving patient outcomes.
• Further research and development are needed for clinical translation, focusing on manufacturing and minimizing immune clearance.